Trial Profile
Effect of Clevidipine on Intracranial Pressure, Cerebral Blood Flow, Brain Tissue Oxygenation and Brain Cellular Metabolism in Severely Hypertensive Patients With Acute Brain Injury.
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase IV
Latest Information Update: 19 Jul 2017
Price :
$35
*
At a glance
- Drugs Clevidipine (Primary)
- Indications Hypertension
- Focus Therapeutic Use
- 25 May 2012 Additional lead trial investigator identified as reported by ClinicalTrials.gov.
- 08 Feb 2012 New trial record